Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations

English version České info

Multidrug-resistant bacteria arise mostly by the accumulation of plasmids and chromosomal mutations. Typically, these resistant determinants are costly to the bacterial cell. Yet, recently, it has been found that, in Escherichia coli bacterial cells, a mutation conferring resistance to an antibiotic can be advantageous to the bacterial cell if another antibiotic-resistance mutation is already present, a phenomenon called sign epistasis. Here we study the interaction between antibiotic-resistance chromosomal mutations and conjugative (i.e., self-transmissible) plasmids and find many cases of sign epistasis (40%)—including one of reciprocal sign epistasis where the strain carrying both resistance determinants is fitter than the two strains carrying only one of the determinants. This implies that the acquisition of an additional resistance plasmid or of a resistance mutation often increases the fitness of a bacterial strain already resistant to antibiotics. We further show that there is an overall antagonistic interaction between mutations and plasmids (52%). These results further complicate expectations of resistance reversal by interdiction of antibiotic use.

Vyšlo v časopise: Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002181
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002181

Souhrn

Zdroje

1. MartinezJLFajardoAGarmendiaLHernandezALinaresJF 2009 A global view of antibiotic resistance. FEMS Microbiol Rev 33 44 65

2. BertinoJS 2009 Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 3 507 521

3. AnderssonDILevinBR 1999 The biological cost of antibiotic resistance. Curr Opin Microbiol 2 489 493

4. AnderssonDI 2006 The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9 461 465

5. LenskiRE 1998 Bacterial evolution and the cost of antibiotic resistance. Int Microbiol 1 265 270

6. NilssonAIBergOGAspevallOKahlmeterGAnderssonDI 2003 Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 47 2850 2858

7. SeppalaHKlaukkaTVuopio-VarkilaJMuotialaAHeleniusH 1997 The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337 441 446

8. EnneVILivermoreDMStephensPHallLM 2001 Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357 1325 1328

9. SchragSJPerrotV 1996 Reducing antibiotic resistance. Nature 381 120 121

10. SchragSJPerrotVLevinBR 1997 Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc B 264 1287 1291

11. Maisnier-PatinSBergOGLiljasLAnderssonDI 2002 Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol Microbiol 46 355 366

12. BjorkmanJNagaevIBergOGHughesDAnderssonDI 2000 Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287 1479 1482

13. GagneuxSLongCDSmallPMVanTSchoolnikGK 2006 The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312 1944 1946

14. TrzcinskiKThompsonCMGilbeyAMDowsonCGLipsitchM 2006 Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 193 1296 1303

15. OrioAGAPinasGECortesPRCianMBEcheniqueJ 2011 Compensatory Evolution of pbp Mutations Restores the Fitness Cost Imposed by beta-Lactam Resistance in Streptococcus pneumoniae. PLoS Path 7 e1002000 doi:10.1371/journal.ppat.1002000

16. DenamurELecointreGDarluPTenaillonOAcquavivaC 2000 Evolutionary implications of the frequent horizontal transfer of mismatch repair genes. Cell 103 711 721

17. BoucherYDouadyCJPapkeRTWalshDABoudreauME 2003 Lateral gene transfer and the origins of prokaryotic groups. Annu Rev Genet 37 283 328

18. CohenOPupkoT 2009 Inference and Characterization of Horizontally Transferred Gene Families using Stochastic Mapping. Mol Biol Evol 27 703 713

19. DionisioFMaticIRadmanMRodriguesORTaddeiF 2002 Plasmids spread very fast in heterogeneous bacterial communities. Genetics 162 1525 1532

20. Amábile-CuevasCFChicurelME 1992 Bacterial Plasmids and Gene Flux. Cell 70 189 199

21. BennettPM 2008 Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153 Suppl 1 S347 357

22. BoumaJELenskiRE 1988 Evolution of a Bacteria Plasmid Association. Nature 335 351 352

23. McDermottPJGowlandPGowlandPC 1993 Adaptation of Escherichia coli growth rates to the presence of pBR322. Lett Appl Microbiol 17 139 143

24. SmithMABidochkaMJ 1998 Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. Can J Microbiol 44 351 355

25. DahlbergCChaoL 2003 Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12. Genetics 165 1641 1649

26. DionisioFConceicaoICMarquesACFernandesLGordoI 2005 The evolution of a conjugative plasmid and its ability to increase bacterial fitness. Biol Lett 1 250 252

27. TrindadeSSousaAXavierKBDionisioFFerreiraMG 2009 Positive Epistasis Drives the Acquisition of Multidrug Resistance. PLoS Genet 5 e1000578 doi:10.1371/journal.pgen.1000578

28. PhillipsPC 2008 Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet 9 855 867

29. SilanderOKTenaillonOChaoL 2007 Understanding the evolutionary fate of finite populations: the dynamics of mutational effects. PLoS Biol 5 e94 10.1371/journal.pbio.0050094

30. PareraMFernandezGClotetBMartinezMA 2007 HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24 382 387

31. BurchCLChaoL 2004 Epistasis and its relationship to canalization in the RNA virus phi 6. Genetics 167 559 567

32. Maisnier-PatinSRothJRFredrikssonANystromTBergOG 2005 Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nat Genet 37 1376 1379

33. JasnosLKoronaR 2007 Epistatic buffering of fitness loss in yeast double deletion strains. Nat Genet 39 550 554

34. van OpijnenTBoerlijstMCBerkhoutB 2006 Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments. J Virol 80 6678 6685

35. ElenaSF 1999 Little evidence for synergism among deleterious mutations in a nonsegmented RNA virus. J Mol Evol 49 703 707

36. CrottySCameronCEAndinoR 2001 RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98 6895 6900

37. SanjuanRMoyaAElenaSF 2004 The contribution of epistasis to the architecture of fitness in an RNA virus. Proc Natl Acad Sci U S A 101 15376 15379

38. ElenaSFLenskiRE 1997 Test of synergistic interactions among deleterious mutations in bacteria. Nature 390 395 398

39. WilkeCOAdamiC 2001 Interaction between directional epistasis and average mutational effects. Proc Biol Sci 268 1469 1474

40. MacLeanRC 2010 Predicting epistasis: an experimental test of metabolic control theory with bacterial transcription and translation. J Evol Biol 23 488 493

41. CarneiroMHartlDL 2010 Adaptive landscapes and protein evolution. Proc Natl Acad Sci U S A 107 Suppl 1 1747 1751

42. CasjensSPalmerNvan VugtRHuangWMStevensonB 2000 A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35 490 516

43. San MillanAEscuderoJAGutierrezBHidalgoLGarciaN 2009 Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids. Antimicrob Agents Chemother 53 3399 3404

44. WardHPerronGGMacleanRC 2009 The cost of multiple drug resistance in Pseudomonas aeruginosa. J Evol Biol 22 997 1003

45. RozenDEMcgeeLLevinBRKlugmanKP 2007 Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 51 412 416

46. WeinreichDMWatsonRAChaoL 2005 Perspective: Sign epistasis and genetic constraint on evolutionary trajectories. Evolution 59 1165 1174

47. HarrBSchlottererC 2006 Gene expression analysis indicates extensive genotype-specific crosstalk between the conjugative F-plasmid and the E. coli chromosome. BMC Microbiol 6 80

48. FisherRFYanofskyC 1983 Mutations of the Beta-Subunit of Rna-Polymerase Alter Both Transcription Pausing and Transcription Termination in the Trp Operon Leader Region Invitro. J Biol Chem 258 8146 8150

49. DrlicaKFrancoRJSteckTR 1988 Rifampin and Rpob Mutations Can Alter DNA Supercoiling in Escherichia-Coli. J Bacteriol 170 4983 4985

50. JinDJGrossCA 1989 Characterization of the Pleiotropic Phenotypes of Rifampin-Resistant Rpob Mutants of Escherichia-Coli. J Bacteriol 171 5229 5231

51. ZengelJMYoungRDennisPPNomuraM 1977 Role of Ribosomal Protein-S12 in Peptide Chain Elongation - Analysis of Pleiotropic, Streptomycin-Resistant Mutants of Escherichia-Coli. J Bacteriol 129 1320 1329

52. JeongKSXieYHiasaHKhodurskyAB 2006 Analysis of pleiotropic transcriptional profiles: A case study of DNA gyrase inhibition. PLoS Genet 2 e152 doi:10.1371/journal.pgen.0020152

53. SchmittCKKempPMolineuxIJ 1995 Streptomycin- and Rifampin-Resistant Mutants of Escherichia-Coli Perturb F-Exclusion of Bacteriophage-T7 by Affecting Synthesis of the F-Plasmid Protein Pifa. J Bacteriol 177 1589 1594

54. OzawaYDe BoeverEHClewellDB 2005 Enterococcus faecalis sex pheromone plasmid pAM373: Analyses of TraA and evidence for its interaction with RpoB. Plasmid 54 57 69

55. WolfsonJSHooperDCSwartzMNMchughGL 1982 Antagonism of the B-Subunit of DNA Gyrase Eliminates Plasmid-Pbr322 and Plasmid-Pmg110 from Escherichia-Coli. J Bacteriol 152 338 344

56. HeXQianWWangZLiYZhangJ 2010 Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks. Nat Genet 42 272 276

57. NormanAHansenLHSorensenSJ 2009 Conjugative plasmids: vessels of the communal gene pool. Philos Trans R Soc Lond B Biol Sci 364 2275 2289

58. WilliamsJJHergenrotherPJ 2008 Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Curr Opin Chem Biol 12 389 399

59. LenskiRERoseMRSimpsonSCTadlerSC 1991 Long-term Experimental Evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am Nat 138: 1315 - 1341